CPT code 83690 – Lipase blood test

Key takeaways

CPT code 83690 covers a quantitative serum or plasma lipase assay, distinct from the amylase assay billed under CPT 82150.

K85.x (acute pancreatitis subtypes) is the primary ICD-10 family for medical necessity, and missing or mismatched diagnosis codes are the top denial cause.

Medicare pays 83690 under the Clinical Laboratory Fee Schedule (CLFS) at a single national limitation amount, so check the current CMS file before billing.

Pabau’s claims management software checks each claim for missing details before it can be sent, which stops avoidable 83690 denials at source.

CPT code 83690: Definition and official descriptor

CPT code 83690 is the American Medical Association (AMA) code for a lipase assay, and its official descriptor is simply “Lipase.”

The short and long descriptors are identical. The code covers a quantitative enzymatic assay of serum or plasma lipase. It is billed once per specimen, however many test runs the lab performs on that sample.

The AMA CPT code set places 83690 in Chemistry (82009-84999) within Pathology and Laboratory (80047-89398).

The once-per-specimen billing rule is the detail most often misread. If a patient provides one blood draw, that is one specimen, billed once. A repeat specimen collected on a different date of service is a separate, billable encounter under 83690.

Lipase testing is classified as moderately complex under CLIA. A physician office lab must therefore hold a CLIA certificate of compliance or accreditation before billing 83690 from an in-office draw. Independent and reference labs bill under their own CLIA number. For practices that refer samples out, the billing entity is the lab that performs the analysis, not the ordering physician.

How lipase assays are performed and documented

Most labs measure serum lipase with an enzymatic colorimetric or turbidimetric assay on an automated analyzer. Fasting is not clinically required, though some labs prefer a fasting specimen to reduce interference from lipemia. The standard collection tube is a serum separator tube (SST) or a lithium-heparin plasma tube. EDTA tubes are generally not recommended, because chelation can interfere with the enzymatic reaction.

Documentation requirements for billing 83690 fall into three categories.

• Physician order: a signed order specifying “lipase” or “serum lipase.” A generic “pancreatic enzymes” order that does not name lipase may not satisfy payer documentation requirements.
• Clinical indication: the ordering provider’s note must record the symptom or diagnosis that prompted the test. Examples are acute epigastric pain radiating to the back, or suspected acute pancreatitis. This links the procedure code to an ICD-10 diagnosis code that establishes medical necessity.
• Lab result report: the quantitative result, reference range, units, and specimen collection date and time. Payers may audit the result report to confirm the test was performed.

A well-documented superbill links the 83690 CPT code to the ICD-10 diagnosis code, the ordering provider NPI, and the date of service. It is the most efficient way to keep this documentation complete at the point of billing.

CPT 83690 vs CPT 82150: Lipase vs amylase

CPT 82150 covers an amylase assay, and CPT 83690 covers a lipase assay. Both measure pancreatic enzyme levels, but the codes are not interchangeable. According to the American College of Gastroenterology (ACG) clinical guidelines, lipase is the preferred enzyme for diagnosing acute pancreatitis.

Lipase stays elevated for about 8-14 days after onset, while amylase typically normalizes within about 3-5 days. That longer window matters clinically. A patient who presents several days after symptom onset may have a normal amylase but a still-elevated lipase.

The most common cross-coding error is billing 82150 when the order says “lipase.” Before assigning the code, coders should confirm which test the lab report shows, rather than relying on the symptom-driven language in the clinical note.

ICD-10 diagnosis codes for medical necessity

Payers cross-reference the diagnosis code on a claim against the procedure code to confirm medical necessity. For CPT code 83690, the primary supported ICD-10 family is K85.x (acute pancreatitis). The subtypes matter. Billing K85.9x (acute pancreatitis, unspecified) when the documentation specifies a cause may result in a specificity-related denial, so code to the highest documented specificity.

Routine lipase testing with no documented symptom or diagnosis, such as a wellness panel, is generally non-covered under most payer LCDs. For Medicare patients where necessity is uncertain, an ABN must be issued before the test is performed. See the ICD-10 code lookup for current code descriptions and effective dates.

Medicare reimbursement and coverage

CPT code 83690 is covered under Medicare Part B and paid under the Clinical Laboratory Fee Schedule (CLFS). The Centers for Medicare and Medicaid Services (CMS) administers it. Established tests like 83690 are paid at a single national limitation amount. The rate does not change from one Medicare Administrative Contractor (MAC) to the next.

Rates reset from private payer data that labs report under the Protecting Access to Medicare Act (PAMA), on a multi-year cycle. CMS publishes quarterly and annual updates. Pull the current 83690 rate from the CMS Clinical Laboratory Fee Schedule files rather than a past year’s figure.

• Independent/reference labs: bill directly to Medicare at the CLFS national rate. No modifier required for a standard single specimen.
• Physician office labs: must hold a CLIA certificate and bill at the CLFS rate. The ordering physician does not separately bill a professional component for CPT 83690.
• Hospital outpatient labs: 83690 is conditionally packaged. It is packaged under the Outpatient Prospective Payment System (OPPS) when billed with other hospital services. When it is the only service on the claim, it is paid at the CLFS rate.
• Inpatient (facility rate): lab services are bundled into the hospital’s DRG payment, so 83690 is not paid separately for an inpatient. An emergency department (ED) visit is a hospital outpatient encounter, so the OPPS rule above applies there.

Medical necessity requirements and LCD criteria

Medicare MACs publish Local Coverage Determinations (LCDs) that define covered indications for CPT code 83690. Covered indications generally include signs and symptoms consistent with acute or chronic pancreatic disease. Examples are epigastric pain, nausea, vomiting, elevated liver enzymes with a possible biliary cause, or a history of pancreatitis with current symptoms. Routine screening without symptoms is not covered.

The medical billing compliance obligation for ABNs is the most commonly mishandled part of 83690 billing. The patient must sign the ABN before the specimen is collected, not after a denial arrives. A retroactive ABN has no force under CMS rules and does not protect the provider from financial liability.

An ABN is required only when there is reason to believe Medicare will deny the claim for medical necessity. It is not required for every lipase order.

Bundling, NCCI edits, and modifier rules

The National Correct Coding Initiative (NCCI), maintained by CMS, defines code pairs that should or should not be billed together. CPT 83690 (lipase) and CPT 82150 (amylase) are not in an NCCI edit pair that automatically bundles one into the other. That means they can be billed on the same date of service when there are clinically distinct indications for both.

CMS updates NCCI edits quarterly, and the CMS NCCI edits page carries the current tables. Verify the edit status before billing any code pair together.

Unbundling means billing 83690 separately when it is included in a panel code the practice also billed on the same date. It is an NCCI violation. Before adding 83690 as a separate line item, check whether lipase is a component of any organ or disease panel your lab bills.

Common denial reasons and prevention strategies

Most CPT 83690 denials fall into five categories. Each has a specific prevention action that stops the denial before it reaches the payer.

Effective denial management for lab codes starts with pre-submission editing. Correcting the ICD-10 pairing and the ABN status before the claim goes out takes far less time than appealing a denial afterward.

For practices tracking denial patterns across a panel of lab codes, the medical billing denial codes reference covers the full CARC/RARC structure. It also shows how to use remittance data to spot repeating denial reasons by code.

Billing CPT 83690 across different practice settings

The setting where the lipase test is performed determines who bills and which payment system applies, as the grid below shows. Coders and billers who work across multiple settings need to apply the right rules for each.

• Independent/reference lab: bills 83690 under its own CLIA number at the national CLFS rate. The ordering provider does not bill the technical component. Lab must be enrolled with the payer.
• Physician office lab (POL): requires a CLIA certificate of compliance or accreditation for moderately complex testing. Bills at the CLFS rate. If the POL refers the sample to a reference lab, the reference lab bills, not the physician office.
• Hospital outpatient department (HOPD): lipase is packaged under OPPS when billed with other hospital services. It is paid at the CLFS rate when it is the only service on the claim.
• Inpatient/ED: for an inpatient, lipase is bundled into the DRG and is not paid as a separate 83690 line. An ED visit follows the HOPD rule above. The ordering physician bills an evaluation and management (E/M) code, not the lab test.

Understanding what makes a clean claim in each setting is the baseline for avoiding setting-based denials. On an HOPD claim, check whether 83690 sits alongside other hospital services. If it does, it is packaged, and if it is the only service, it is paid at the CLFS rate.

How claims management software reduces CPT 83690 denials

Most 83690 denials trace back to details that were wrong before submission. A missing diagnosis code, an unchecked Medicare status, or an unsigned ABN usually surfaces only when the remittance advice arrives. By then, the fix means an appeal.

In Pabau, the practice management platform we build, the Claim.MD clearinghouse integration checks a patient’s coverage in real time before the specimen is collected. Claims are generated from the invoices your team already raises and sent electronically to US payers.

Pabau’s claims management software runs validation checks every time you go to send a claim. If a required detail is missing, the Send button stays disabled until it’s fixed. Claim statuses then update from the payer, and electronic remittance advice posts back against the invoice it settles.

Reduce CPT 83690 denials before they happen

Pabau generates claims from your invoices, checks them for missing details before they go out, and submits them through Claim.MD. See how it handles lab billing in a live demo.

Book a demo

Conclusion

If you fix one part of your 83690 workflow first, make it the diagnosis pointer. Mismatched ICD-10 codes cause more lipase denials than any other reason, and checking them at order entry takes seconds.

ABN timing comes next, because a retroactive ABN can’t be repaired later. Once both are routine, hospital outpatient packaging is the remaining risk, and it is worth an occasional audit.

Pabau keeps the eligibility check, the claim, and the remittance in one medical billing workflow. A lipase denial is then quick to trace back to its cause. Book a demo to see how it handles lab claims for your practice.

Continue your research

Need to understand how clearinghouse claim validation works? Pabau’s Claim.MD clearinghouse guide explains how electronic claims are scrubbed, validated, and submitted to payers, with notes on eligibility verification and ERA processing.

Want a structured reference for electronic remittance codes? Electronic remittance advice explained covers the 835 transaction, CARC and RARC codes, and how to reconcile ERA data against your billing system.

Looking to verify insurance eligibility before ordering lab tests? Insurance eligibility verification outlines the real-time 270/271 transaction process and how to catch coverage problems before claims are filed.

Frequently asked questions